Log in

NASDAQ:CPIX - Cumberland Pharmaceuticals Stock Price, Forecast & News

$5.10
-0.09 (-1.73 %)
(As of 01/17/2020 04:00 PM ET)
Today's Range
$5.04
Now: $5.10
$5.22
50-Day Range
$4.79
MA: $5.15
$5.37
52-Week Range
$4.19
Now: $5.10
$6.99
Volume29,619 shs
Average Volume16,282 shs
Market Capitalization$77.42 million
P/E RatioN/A
Dividend YieldN/A
Beta0.14
Cumberland Pharmaceuticals Inc, a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and oncology markets in the United States and internationally. It offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative, for the treatment of chronic and acute constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol injection for treating hyponatremia; Ethyol injection for the reduction of xerostomia; Totect injection, for emergency oncology intervention, to treat the toxic effects of anthracycline chemotherapy; and Vibativ injection, for the treatment of certain serious bacterial infections. Read More…

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryPharmaceuticals
SectorMedical
Current SymbolNASDAQ:CPIX
CUSIP23077010
Phone615-255-0068

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$40.74 million
Cash Flow$0.07 per share
Book Value$3.58 per share

Profitability

Net Income$-6,960,000.00

Miscellaneous

Employees80
Market Cap$77.42 million
Next Earnings Date2/25/2020 (Estimated)
OptionableOptionable

Receive CPIX News and Ratings via Email

Sign-up to receive the latest news and ratings for CPIX and its competitors with MarketBeat's FREE daily newsletter.


5G Flaw Exposed: $5 Stock Holds Key To $12 Trillion Opportunity (Ad)


A devastating technical glitch could crush the next generation of wireless technology before it even launches. With trillions of dollars and millions of jobs at stake, one company with the "5G fix" could put as much as $234,770 in your pocket this year. But Wall Street vultures are circling... you'll need to move quickly or risk missing this $5 bargain.

Cumberland Pharmaceuticals (NASDAQ:CPIX) Frequently Asked Questions

What is Cumberland Pharmaceuticals' stock symbol?

Cumberland Pharmaceuticals trades on the NASDAQ under the ticker symbol "CPIX."

How were Cumberland Pharmaceuticals' earnings last quarter?

Cumberland Pharmaceuticals, Inc. (NASDAQ:CPIX) posted its quarterly earnings results on Tuesday, November, 12th. The specialty pharmaceutical company reported $0.01 EPS for the quarter, missing the Thomson Reuters' consensus estimate of $0.11 by $0.10. The specialty pharmaceutical company earned $10.37 million during the quarter, compared to analyst estimates of $12.65 million. Cumberland Pharmaceuticals had a negative net margin of 10.13% and a positive return on equity of 6.76%. View Cumberland Pharmaceuticals' Earnings History.

When is Cumberland Pharmaceuticals' next earnings date?

Cumberland Pharmaceuticals is scheduled to release their next quarterly earnings announcement on Tuesday, February 25th 2020. View Earnings Estimates for Cumberland Pharmaceuticals.

What price target have analysts set for CPIX?

1 brokerages have issued 12-month price targets for Cumberland Pharmaceuticals' stock. Their forecasts range from $9.75 to $9.75. On average, they expect Cumberland Pharmaceuticals' stock price to reach $9.75 in the next year. This suggests a possible upside of 91.2% from the stock's current price. View Analyst Price Targets for Cumberland Pharmaceuticals.

What is the consensus analysts' recommendation for Cumberland Pharmaceuticals?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cumberland Pharmaceuticals in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Cumberland Pharmaceuticals.

Has Cumberland Pharmaceuticals been receiving favorable news coverage?

News coverage about CPIX stock has trended very negative recently, InfoTrie reports. InfoTrie rates the sentiment of press coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Cumberland Pharmaceuticals earned a daily sentiment score of -3.8 on InfoTrie's scale. They also gave news headlines about the specialty pharmaceutical company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View News Stories for Cumberland Pharmaceuticals.

Are investors shorting Cumberland Pharmaceuticals?

Cumberland Pharmaceuticals saw a decrease in short interest in the month of December. As of December 31st, there was short interest totalling 82,400 shares, a decrease of 12.7% from the December 15th total of 94,400 shares. Based on an average trading volume of 14,900 shares, the days-to-cover ratio is presently 5.5 days. Currently, 0.9% of the company's shares are short sold. View Cumberland Pharmaceuticals' Current Options Chain.

Who are some of Cumberland Pharmaceuticals' key competitors?

What other stocks do shareholders of Cumberland Pharmaceuticals own?

Who are Cumberland Pharmaceuticals' key executives?

Cumberland Pharmaceuticals' management team includes the folowing people:
  • Mr. A. J. Kazimi, Founder, Chairman, Pres & CEO (Age 61)
  • Mr. Michael P. Bonner, CFO and Sr. Director of Fin. & Accounting (Age 42)
  • Mr. Leo B. Pavliv, Exec. VP of Operations & Chief Devel. Officer (Age 58)
  • Mr. James Lowrance Herman, Sr. VP of National Accounts & Chief Compliance Officer (Age 64)
  • Mr. Martin E. Cearnal, Exec. VP of Marketing & Sales, Chief Commercial Officer and Director (Age 74)

How do I buy shares of Cumberland Pharmaceuticals?

Shares of CPIX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Cumberland Pharmaceuticals' stock price today?

One share of CPIX stock can currently be purchased for approximately $5.10.

How big of a company is Cumberland Pharmaceuticals?

Cumberland Pharmaceuticals has a market capitalization of $77.42 million and generates $40.74 million in revenue each year. The specialty pharmaceutical company earns $-6,960,000.00 in net income (profit) each year or ($0.12) on an earnings per share basis. Cumberland Pharmaceuticals employs 80 workers across the globe.View Additional Information About Cumberland Pharmaceuticals.

What is Cumberland Pharmaceuticals' official website?

The official website for Cumberland Pharmaceuticals is http://www.cumberlandpharma.com/.

How can I contact Cumberland Pharmaceuticals?

Cumberland Pharmaceuticals' mailing address is 2525 WEST END AVENUE SUITE 950, NASHVILLE TN, 37203. The specialty pharmaceutical company can be reached via phone at 615-255-0068 or via email at [email protected]


MarketBeat Community Rating for Cumberland Pharmaceuticals (NASDAQ CPIX)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  160 (Vote Outperform)
Underperform Votes:  208 (Vote Underperform)
Total Votes:  368
MarketBeat's community ratings are surveys of what our community members think about Cumberland Pharmaceuticals and other stocks. Vote "Outperform" if you believe CPIX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CPIX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/18/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel